top of page
GALA-24-01 Dallas Conference Banner_v1.jpg

May 10-11, 2024

GALA-24-01 Dallas Conference_logo.png

The Westin Dallas Southlake

Southlake, Texas

SOCIETY ENDORSEMENTS

NTSGNA_highres.png
TSGE-logo.png

COURSE DIRECTORS

schiller.png

Lawrence Schiller, MD

Chair, Institutional Review Boards
Baylor University Medical Center
Dallas, Texas

mitchell.png

Mack Mitchell, MD

Vice President for Medical Affairs
University of Texas Southwestern Medical Center
Dallas, Texas

FACULTY

brown.png

Kimberly Brown, MD

Henry Ford Hospital
Detroit, Michigan

chey.png

William Chey, MD

​University of Michigan
Ann Arbor, Michigan

fass.png

Ronnie Fass, MD

MetroHealth Medical Center
Detroit, Michigan

flamm.png

Steven Flamm, MD

Rush University Medical Center
Chicago, Illinois

hanauer.png

Stephen Hanauer, MD

Northwestern University
Chicago, Illinois

hans.png

Amneet Hans, MD

Baylor University Medical Center
Dallas, Texas

horton.png

Jay Horton, MD

University of Texas
Southwestern Medical Center
Dallas, Texas

kedia.png

Prashant Kedia, MD

Methodist Dallas Medical Center
Dallas, Texas

kwo.png

Paul Kwo, MD

Stanford Medicine
Palo Alto, California

lukin.png

Dana Lukin, MD, PhD

 Weill Cornell Medicine
New York, New York

petrasek.png

Jan Petrasek, MD, PhD

UT Health San Antonio
San Antonio, Texas

reau.png

Nancy Reau, MD

Rush University Medical Center
Chicago, Illinois

vaezi.png

Michael Vaezi, MD, PhD

Vanderbilt University Medical Center
Nashville, Tennessee

veirling.png

John Vierling, MD

Baylor College of Medicine
Houston, Texas

AGENDA

Friday, May 10, 2024
 

11:45 AM              
Lunch and Registration

 

12:00 PM - 12:45 PM

Learn About Omvoh™️: Some Discoveries Are Too Urgent To Ignore

Shadi Hamdeh, MD and Sharon Rimon, NP
Industry-Sponsored Event (Non-accredited)

Sponsored by Eli Lilly


12:50 PM - 1:05 PM                  
Welcome

 
Session I
 

1:05 PM - 1:30 PM                 

Primary Biliary Cholangitis (PBC):Health Related Quality of Life and Emerging Therapies

John Vierling, MD


1:30 PM - 1:55 PM                        

Managing the Patient with Alcohol-associated Hepatitis 

Jan Petrasek, MD, PhD

1:55 PM - 2:20 PM                      
Advanced Cirrhosis: Recognizing and Managing Complications of Portal Hypertension

Paul Kwo, MD

2:20 PM - 2:35 PM                        
Q&A
/ Panel Discussion
 

2:35 PM – 2:50 PM                  
Break

Session II

2:50 PM - 3:15 PM                        

Positioning New Therapies For Inflammatory Bowel Disease (IBD)

Stephen Hanauer, MD

3:15 PM - 3:40 PM                        
Managing Inflammatory Bowel Disease (IBD) During Pregnancy

Amneet Hans, MD

3:40 PM - 4:05 PM                        

Managing Perianal Crohn’s Disease 

Dana Lukin, MD, PhD

4:05 PM - 4:30 PM                  
Q&A / Panel Discussion

4:30 PM – 5:30 PM              

Major Advancement in MASH Management
Parvez S. Mantry, MD
Independent Symposium (Accredited)
Provided by the Chronic Liver Disease Foundation and the Global NASH Council


 

5:30 PM - 7:00 PM                        
Reception

Saturday, May 11, 2024

7:15 AM              

Breakfast and Registration

7:30 AM - 8:15 AM 

Industry-Sponsored Event (Non-accredited) 

Sponsored by Johnson & Johnson

8:20 AM – 8:25 AM                  
Welcome Back

Session III
 

8:25 AM – 8:55 AM                 
Managing Refractory GERD

Ronnie Fass, MD

8:55 AM - 9:25 AM       

Eosinophilic Esophagitis in 2024:
Standard and Emerging Treatments

Michael Vaezi, MD, PhD

9:25 AM - 9:55 AM                     
Management of Pancreatic Cysts  

Prashant Kedia, MD

9:55 AM - 10:20 AM                  
Q&A / Panel Discussion


10:20 AM – 10:35 AM              
Break

 

10:35 AM - 11:35 AM              
Parallel Session (Select One)

  • Upper GI Woes from Head to Toe

  • Inflammatory Bowel Disease, Irritable Bowel Syndrome,  and Pancreas

  • Obesity and Steatosis

  • Chronic Liver Disease
     

11:35 AM - 11:50 AM                 
Lunch Break

 

11:50 AM - 12:35 PM               

Now Approved: Rezdiffra™️ (resmetirom) 
A New Treatment Option

Kimberly Brown, MD
Industry-Sponsored Event (Non-accredited)
Sponsored By Madrigal Pharmaceuticals


Session IV


12:35 PM - 1:00 PM                        
Metabolic-Associated Steatotic Liver Disease: Positioning New and Emerging Therapies

Nancy Reau, MD


1:00 PM - 1:45 PM                        

Steatotic Liver Disease: Using Non-invasive Tests (NITs) to Measure Disease Progression (PRO/CON)
Steve
n Flamm, MD, and Kimberly Brown, MD

1:45 PM - 2:15 PM                        

Managing Obesity in the Community

Jay Horton, MD

              

2:15 PM - 2:40 PM                        
Q&A / Panel Discussion

2:40 PM - 2:55 PM                        
Break

 

Session V

2:55 PM - 3:25 PM                        

Best Practices for Chronic Constipation

William Chey, MD

3:25 PM - 3:55 PM                      
Getting the BS out of IBS-D: Let’s Make a Diagnosis

Lawrence Schiller, MD
                                                       
3:55 PM - 4:15 PM                        
Q&A / Panel Discussion

4:15 PM - 4:30 PM                    
Meeting Wrap-up

Faculty
Agenda
Venue

VENUE

The Westin
Dallas Southlake

1200 E. State HWY 114
Southlake, TX 76092

Subscribe to get GALA updates!

Thanks for subscribing!

This activity is supported by educational grants from Intercept Pharmaceuticals, Inc., Ipsen Biopharmaceuticals, Inc., and Salix Pharmaceuticals.

This activity is jointly provided by the Annenberg Center for Health Sciences at Eisenhower, the Gastrointestinal and Liver Association of the Americas, and the Texas Liver Institute.

ACHS_New_Logo_4L.png
GALA.png
TLI.png
Subscribe
bottom of page